Table 4.
Predictors of treatment outcomes among children treated for pneumonia at the pediatric ward of Tikur Anbessa Specialized Hospital from February 2017 to February 2018, Addis Ababa, Ethiopia.
| Variable | Treatment outcome | Corollary (95% CI) | AOR (95% CI) | ||
|---|---|---|---|---|---|
| Good | Poor | ||||
| Age | <1 month | 1 | 1 | 1 | 1 |
| 1 month–1 year | 121 | 9 | 0.074 (0.004–1.3) | 4.4 (0.015–13.2) | |
| 1 year–3 years | 45 | 1 | 0.022 (0.001–.67)∗ | 0.77 (0.01–73.2) | |
| 3 years–6 years | 14 | 2 | 0.143 (0.006–3.3) | 0.27 (0.003–26.8) | |
| >6 years | 10 | 2 | 0.300 (0.014–6.4) | 1.2 (0.05–27.7) | |
|
| |||||
| Weight (kg) | 1–5 kg | 19 | 4 | 1 | 1 |
| 6–10 kg | 132 | 6 | 0.216 (0.056–0.84)∗ | 1.139 (0.11–118.3) | |
| 11–15 kg | 28 | 2 | 0.339 (0.056–2.041) | 0.2.43 (0.03–17.6) | |
| >16 kg | 12 | 4 | 1.58 (0.332–7.56) | 0.396 (0.013–12.4) | |
|
| |||||
| Antibiotic administered | Crystalline penicillin | 107 | 4 | 1 | 1 |
| Ampicillin + gentamycin | 11 | 1 | 2.43 (0.25–23.7) | 1.83 (0.072–46.57) | |
| Ceftriaxone | 43 | 3 | 1.86 (0.40–8.6) | 1.61 (0.24–10.96) | |
| Ceftriaxone + gentamycin | 14 | 1 | 1.91 (0.19–18.3) | 0.887 (0.08–9.4) | |
| Ceftriaxone + azithromycin | 7 | 2 | 7.6 (1.8–49.2)∗ | 0.086 (0.01–0.83)∗ | |
| Vancomycin | 4 | 3 | 20.1 (3.32–121.3)∗ | 0.123 (0.011–1.35) | |
| Ceftriaxone + metronidazole | 5 | 2 | 10.7 (1.6–72.9)∗ | 0.241 (0.024–2.4) | |
|
| |||||
| Hospital stay (days) | ≤3 | 25 | 2 | 1 | 1 |
| 4–5 | 77 | 4 | 0.65 (0.112–3.76) | 0.828 (0.137–5.01 | |
| 6–7 | 61 | 2 | 0.41 (0.055–31)∗ | 3.73 (0.59–23.4 | |
| ≥8 | 28 | 8 | 3.57 (1.9–18.4) | 14.30 (1.35–51.1)∗ | |